Congress cuts prescription copays for low-income seniors and disabled Medicare beneficiaries
H.R. 4139 — Cutting Copays Act · Filed by Morgan McGarvey (D-KY) · 1 cosponsor · Introduced Jun 25, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reduces out-of-pocket costs for low-income Medicare beneficiaries under Part D (prescription drug coverage). Starting immediately, it caps copays at $1 for generic and preferred multi-source drugs and $3 for other drugs. Beginning in 2026, generic drugs become free for low-income individuals, and other drugs revert to 2023 copay levels, then adjust annually for inflation.
Why we flagged it
The bill's sole operative mechanism is to reduce copay obligations for low-income Part D beneficiaries through lower fixed caps and eventual free generics. It is a straightforward entitlement expansion targeting a vulnerable population.
What the text implies
- Pharmaceutical manufacturers may face reduced revenue from generic drugs if lower copays increase utilization among price-sensitive low-income beneficiaries, though the effect depends on demand elasticity.
- Plan sponsors (insurers) administering Part D may experience margin pressure if copay reductions are not offset by CMS reimbursement adjustments or if utilization increases materially.
The full analysis lists 3 implications of this text.
Who stands to gain
low-income Medicare beneficiaries (seniors and disabled individuals)